Shearman & Sterling LLP represented Cowen and Company acting as placement agent in connection with a $300 million equity PIPE, issued in connection with the business combination of Pacific Biosciences of California (Nasdaq: PACB) and Omniome which was announced on September 20, 2021.

Pacific Biosciences of California is a leading provider of high-quality, long-read sequencing platforms, and Omniome is a San Diego-based biotechnology company developing a proprietary and highly differentiated short-read sequencing platform capable of delivering increased sequencing accuracy.

The Team